Dr. Haifeng Ye received his Ph.D degree and completed his Postdoctoral Research from Swiss Federal Institute of Technology Zurich (ETH Zürich) in the group of Prof. Dr. Martin Fussenegger. He started his own group in the School of Life Sciences at East China Normal University (ECNU) in 2014. His research interest has been focused on synthetic biology and biomedical engineering with the goal to achieve precise diagnosis and treatment of diseases. His research topics include optogenetics-based precision medicine, synthetic gene circuits for gene- and cell-based therapy, synthetic biology-based cancer therapy and precise controlled gene editing. His research work was published in the scientific journals: Science, Science Translational Medicine (2017, 2019), Nature Biomedical Engineering, PNAS, etc. His research was also highlighted by a series of scientific journals: Cell, Nature Medicine, Nature Chemical Biology, Nature Reviews Molecular Cell Biology and received international press coverage: Xinhua News Agency, CCTV, BBC, EurekaAlert@AAAS, MIT Technology Review, ScienceDaily, IEEE Spectrum, ScienceDaily, FOCUS, Discover, etc.